Novation contracts Amersham for nuclear medicine products

TriMed Staff | | Health Imaging | Practice Management
Amersham Health has received a three-year contract from Novation for its nuclear medicine radiopharmaceutical and related products.

 The pact is effective Jan. 1, 2004 through Dec. 31, 2006.

 The Buckinghamshire, United Kingdom company will provide the group purchasing company with products, such as its Myoview kit for the preparation of Technetium Tc99m and Tetrofosmin injection for myocardial perfusion.

 Novation is the supply company of VHA Inc., based in Irving, Texas, and University HealthSystem Consortium (UHC), which operates from Oakbrook, Ill.

TriMed Staff

Related Content

Warning: Sidelined reactor could trigger medical isotope shortage
Malpractice watchers: Radiologists, imaging societies should bone up on the ‘science of visual perception’
ACR shares guidance for radiology providers facing IV supply shortages after hurricane
Incidental finding characteristics that warrant communication
AI implementation improves when radiology staff concerns are considered
Hospital organization sees impressive returns from POCUS integration

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.